NexgenRx Announces First Quarter of 2014 Results
29 May 2014 - 6:12AM
Marketwired
NexgenRx Announces First Quarter of 2014 Results
TORONTO, ONTARIO--(Marketwired - May 28, 2014) - NEXGENRX INC.
("NexgenRx" or the "Corporation") (TSX-VENTURE:NXG) is pleased to
announce its first quarter of 2014 results.
For the first
quarter ended March 31, 2014 transaction and administration revenue
was $1,034,006, generating gross profit of $817,261 and a net loss
was $58,500.
"In the first
quarter of 2014, while our new sales revenue increased, we did feel
the full impact of one of our major client's decisions to migrate
their claims processing in house. The loss of this revenue was
partially offset by our new sales revenue and organic growth of
over $300,000 during the quarter which provides the confidence in
our ability to recover the lost revenue during the year." stated
Ron Loucks, President and CEO.
About NexgenRx
NexgenRx is a
growing health benefits management company engaged in the design,
management and administration of health benefit plans offered by
employers and other plan sponsors for the benefit of their
employees and plan members. More information on NexgenRx can be
found at www.nexgenrx.com.
Caution Regarding
Forward-Looking Statements - This news release contains certain
forward looking statements, including statements regarding the
business and anticipated financial performance of the Corporation.
These statements are subject to a number of risks and
uncertainties. Actual results may differ materially from results
contemplated by the forward-looking statements. When relying on
forward-looking statements to make decisions, investors and others
should carefully consider the foregoing factors and other
uncertainties and should not place undue reliance on such
forward-looking statements.
"Neither TSX
Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of the
release."
NexgenRx Inc.Ronald C. LoucksPresident and CEO416.695.3393
x801NexgenRx Inc.Taba MerrikhDirector of
Finance416-695-3393x803www.nexgenrx.com
Nexgenrx (TSXV:NXG)
Historical Stock Chart
From Dec 2024 to Jan 2025
Nexgenrx (TSXV:NXG)
Historical Stock Chart
From Jan 2024 to Jan 2025
Real-Time news about Nexgenrx Inc (TSX Venture Exchange): 0 recent articles
More Nexgenrx Inc. News Articles